Skip to main content
Noa Biran, MD, Oncology, Hackensack, NJ, Hackensack Meridian Health Hackensack University Medical Center

NoaBiranMD

Oncology • Hackensack, NJ

Hematologic Oncology

Physician

Request Appointment

Overview of Dr. Biran

Dr. Noa Biran is an oncologist in Hackensack, NJ and is affiliated with Hackensack Meridian Health Hackensack University Medical Center. She received her medical degree from George Washington University School of Medicine and has been in practice 9 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.

As a physician in the Myeloma Division at John Theurer Cancer Center, my research is focused on high-risk multiple myeloma patients with refractory disease, many of whom have been through multiple lines of treatment. Our most promising therapy at this time is BCMA directed CAR-T cell therapy, which uses T-cells that are reengineered to target multiple myeloma. The response rate has been close to 80% in some. We are also exploring other drug therapies, including genetic approaches to treatment, and starting to move these treatment strategies to earlier in the patient’s therapy in the hopes of generating a longer remission.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2008 - 2011
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2026
  • NJ State Medical License
    NJ State Medical License 2014 - 2025
  • PA State Medical License
    PA State Medical License 2023 - 2024

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational Study  
    Noa Biran, Andrew Ip, Ronaldo Collo Go, The Lancet Rheumatology

Abstracts/Posters

  • Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
    Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Building a National CML Registry
    Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 Patients
    Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treat... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Authored Content

  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020
  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020

Press Mentions

  • John Theurer Cancer Center Investigators Present Pioneering Research at the American Society of Hematology Annual Conference
    John Theurer Cancer Center Investigators Present Pioneering Research at the American Society of Hematology Annual ConferenceDecember 9th, 2021
  • John Theurer Cancer Center (JTCC) Researchers to Present 52 Abstracts Across Hematological Malignancies at the 2020 American Society of Hematology (ASH) Annual Meeting and Exposition
    John Theurer Cancer Center (JTCC) Researchers to Present 52 Abstracts Across Hematological Malignancies at the 2020 American Society of Hematology (ASH) Annual Meeting and ExpositionDecember 4th, 2020
  • Dr. Biran on Post-ASCT Consolidation in Multiple Myeloma
    Dr. Biran on Post-ASCT Consolidation in Multiple MyelomaJanuary 31st, 2020
  • Join now to see all

Hospital Affiliations

Dr. Noa Biran, Dr. Noa Biran, MD, Dr. N Biran